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Abstract
Background: The pyridoxal-5'-phosphate (PLP)-dependent or vitamin B6-dependent enzymes
that catalyze manifold reactions in the metabolism of amino acids belong to no fewer than four
evolutionarily independent protein families. The multiple evolutionary origin and the essential
mechanistic role of PLP in these enzymes argue for the cofactor having arrived on the evolutionary
scene before the emergence of the respective apoenzymes and having played a dominant role in
the molecular evolution of the B6 enzyme families. Here we report on an attempt to re-enact the
emergence of a PLP-dependent protoenzyme. The starting protein was pancreatic ribonuclease A
(RNase), in which active-site Lys41 or Lys7 readily form a covalent adduct with PLP.
Results: We screened the PLP adduct of wild-type RNase and two variant RNases (K7R and
K41R) for catalytic effects toward L- and D-amino acids. RNase(K41R)-PLP, in which the cofactor
is bound through an imine linkage to Lys7, qualifies for a model proto-B6 enzyme by the following
criteria: (1) covalent linkage of PLP (internal aldimine); (2) catalytic activity toward amino acids that
depends on formation of an imine linkage with the substrate (external aldimine); (3) adjoining
binding sites for the cofactor and amino acid moiety that facilitate the transimination reaction of
the internal to the external aldimine and stabilize the resulting noncovalent complex of the
coenzyme-substrate adduct with the protein; (4) reaction specificity, the only detectable reactions
being racemization of diverse amino acids and β-decarboxylation of L-aspartate; (5) acceleration
factors for racemization and β-decarboxylation of >103 over and above that of PLP alone; (6)
ribonuclease activity that is 103-fold lower than that of wild-type RNase, attenuation of a pre-
existing biological activity being indispensable for the further evolution as a PLP-dependent
protoenzyme.
Conclusion: A single amino acid substitution (Lys41Arg) and covalent binding of PLP to active-site
Lys7 suffice to turn pancreatic ribonuclease A into a protein catalyst that complies with all plausible
criteria for a proto-B6 enzyme. The study thus retraces in a model system what may be considered
the committed step in the molecular evolution of a potential ancestor of a B6 enzyme family.
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Background
Pyridoxal 5'-phosphate (PLP), a derivative of vitamin B6,
is one of the most versatile coenzymes and serves as pros-
thetic group of glycogen phosphorylase and numerous
enzymes that catalyze manifold reactions of amino acids
such as racemization, transamination, decarboxylation,
aldol cleavage, as well as β- and γ-elimination and replace-
ment reactions. In all PLP-dependent enzymes (B6
enzymes) that act on amino acid substrates the cofactor is
bound through an imine linkage to the ε-amino group of
an active-site lysine residue (internal aldimine 1; Fig. 1).
Hence, in all transformations of amino acids that are cat-
alyzed by B6 enzymes the first covalency change is the
same: through transimination the ε-amino group of the
lysine residue is exchanged with the α-amino group of the
amino acid substrate to form the planar external aldimine
2 with its extended π system. The external aldimine inter-
mediate may then proceed along different reaction path-
ways resulting in the manifold PLP-dependent
transformations of amino acids. The cleavage of one of the
bonds at Cα gives rise to the quinonoid intermediate 3;
the bond that is cleaved and the following covalency
changes determine which particular transformation of the
amino acid substrate is implemented (Fig. 1; for a concise
review, see [1]). All reactions catalyzed by B6 enzymes are
assumed to occur also, albeit very slowly, with amino acid
substrates and PLP alone. The protein moiety of a given B6
enzyme modulates the intrinsic chemical disposition of
the coenzyme-substrate adduct and determines which of
the many possible pathways the adduct will adopt.
The B6 enzymes that act on amino acids belong to four
independent evolutionary lineages [2-5]. The first step in
the emergence of a B6 enzyme family very likely was the
reaction of PLP with a lysine residue of a protoapoen-
zyme. The four progenitor B6  enzymes were selected
among the available protoenzymes and, during a time
period of at least 3000 million years, optimized their cat-
alytic apparatus and specialized into the modern B6
enzymes with distinct reaction and substrate specificities
and enormously increased catalytic efficiency [4,5]. In a
previous attempt to generate de novo a PLP-dependent
protein catalyst, PLP-dependent catalytic antibodies have
been generated. In contrast to the modern B6 enzymes and
their hypothetical protoenzymes, the catalytic antibodies,
due to the immunization and selection protocol, do not
bind PLP covalently [6-8].
Here we report an alternative approach to retracing the
early steps in the evolution of B6 enzymes. We explored
the catalytic capacity of a covalent adduct of a non-B6 pro-
tein with PLP. Before the advent of the technique of site-
directed mutations, PLP has been widely used for lysine-
specific chemical modification of proteins [9,10]. Bovine
pancreatic ribonuclease A (RNase), which catalyzes the
cofactor-independent endonucleolytic hydrolysis of RNA,
was chosen for this study because its three-dimensional
structure is known [11] and its physical, chemical and
enzymic properties have been extensively investigated (for
reviews, see [12-14]. The phosphate subsites interacting
with the RNA substrate [15] endow the active site of
RNase with high affinity for phosphate groups; RNase has
Intermediates in protein-assisted PLP-dependent racemization and β-decarboxylation Figure 1
Intermediates in protein-assisted PLP-dependent racemization and β-decarboxylation. Only the reactions found 
to be catalyzed by the RNase-PLP adduct are depicted; not shown are the pathways for transamination, α-decarboxylation, 
Cα-Cβ cleavage, β/γ-elimination, and β/γ-substitution.
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indeed been reported to bind PLP covalently in a mutually
exclusive fashion at the ε-NH2 group of either Lys7 or
Lys41 [16-18] as well as to a lesser extent at the α-NH2
group of Lys1 [19]. We screened the PLP adduct of wild-
type RNase and of two mutant RNases (K7R and K41R)
with a single lysine residue at the active site for catalytic
effects toward a series of L- and D-amino acids.
RNase(K41R)-PLP showed catalytic properties as they
might be expected from a PLP-dependent protoenzyme. It
catalyzed with remarkable specificity the racemization of
alanine and aspartate as well as the β-decarboxylation of
L-aspartate. These reactions were at least three orders of
magnitude faster than the corresponding unmeasurably
slow reactions of the amino acids with PLP alone in the
absence of RNase.
Results
RNase-PLP adduct
The aldimine adduct of PLP and either Lys41 or Lys7 of
RNase formed immediately after mixing RNase and PLP at
equimolar concentrations. The absorption maximum at
388 nm, typical of the free cofactor in aldehyde form [20],
shifted to 408 nm (Fig. 2) as is characteristic for the aldi-
mine of RNase with PLP [17]. Spectrophotometric deter-
mination of the concentration of PLP after dissociation of
the adduct in 0.1 N NaOH (see Methods) showed that
RNase bound PLP in a 1:1 molar ratio. Steric reasons pre-
clude double aldimine formation at Lys7 and Lys41; at pH
6.0, PLP attaches to Lys41 or Lys7 in a 3:2 ratio [17]. The
proximity of these lysine residues to a phosphate-binding
subsite of the enzyme seems to be critical for aldimine for-
mation; phosphate ions compete with PLP for binding to
RNase [21]. The mixture of the aldimine adducts of RNase
with PLP either at Lys41 or at Lys7 was analyzed for its
capacity to catalyze PLP-dependent reactions of a series of
neutral aliphatic, acidic, basic and aromatic amino acids.
The mixed adducts were found to accelerate the racemiza-
tion of alanine (Fig. 3) and at a slightly slower rate of
dicarboxylic and aromatic amino acids. β-Decarboxyla-
tion of L-aspartate to L-alanine also took place, whereas
no β-decarboxylation of D-aspartate was detected (Table
1). No transaminase activity, i.e. formation of pyridoxam-
ine-5'-phosphate (PMP), was detected by spectrophotom-
etry (see Methods) with any of the tested substrates.
Although the rates of the PLP-dependent reactions that
were catalyzed by RNase-PLP were slow, they by far (>103)
exceeded those of the unmeasurably slow control reac-
tions without RNase; neither consumption of substrate
nor formation of products were detected after incubation
of all tested amino acids with PLP in the absence of RNase
with the exception of the racemization of L- and D-gluta-
mate (Table 1). Likewise, no amino acid transformations
were detected in controls containing amino acids and
RNase without PLP. Reduction of the internal aldimine
bond [17] completely and irreversibly abolished the PLP-
dependent catalytic activities of RNase indicating that
they require the formation of covalent coenzyme-sub-
strate adducts (Fig. 1). The reduction of the internal aldi-
mine bond of the RNase-PLP adduct was monitored by
Racemization of L-alanine by RNase-PLP adduct Figure 3
Racemization of L-alanine by RNase-PLP adduct. 
RNase-PLP (11 mM) was incubated with 20 mM L-alanine in 
50 mM 4-methylmorpholine pH 7.5 at 25°C. Samples (20 μl) 
were withdrawn at the indicated times and analyzed by deri-
vatization with Marfey reagent and subsequent HPLC (for 
details, see Materials and Methods). The mean values ± SE of 
5 different experiments are shown. Similar data were 
obtained with D-alanine as substrate.
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Formation of internal aldimine between PLP and RNase Figure 2
Formation of internal aldimine between PLP and 
RNase. (---) Absorption spectrum of 30 μM PLP in 50 mM 
4-methylmorpholine pH 7.5 at 25°C; (—) spectrum upon 
addition of 30 μM of RNase.
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the disappearance of the absorption maximum of the ald-
imine at 408 nm and the appearance of an absorption
peak at 325 nm.
Recombinant wild-type and variant RNase-PLP adducts
To eliminate the ambiguity of PLP attaching either to Lys7
or Lys41 and possibly to improve the PLP-dependent cat-
alytic activity of RNase-PLP, Lys7 and Lys41 were sepa-
rately replaced by an arginine or alanine residue.
Recombinant wild-type and the four mutant RNases
(K41R, K41A, K7R, K7A) were purified from E. coli cells to
homogeneity, and their ribonuclease activity was meas-
ured (Table 2). K41R and K41A retained only 0.1% and
0.01%, respectively, of the ribonuclease activity of the
wild-type enzyme. Lys41 has indeed been reported to par-
ticipate directly in the catalytic mechanism of ribonucle-
ase [22]. In contrast to the K41 variants, K7R and K7A
retained 98% and 22%, respectively, of the wild-type
RNase activity.
To assess the binding affinity of wild-type and variant
RNases for PLP, RNase and PLP were mixed at equimolar
concentration. After size-exclusion chromatography, the
wild-type protein, RNase(K41R) and RNase(K7R) showed
an absorption maximum at 408, 400 and 396 nm, respec-
tively, as is characteristic of the aldimine adduct. The PLP/
RNase molar ratio was determined after dissociation of
PLP from the protein with NaOH (see Methods) and was
found to be 1.0 for the wild-type enzyme and K7R, and
0.8 for K41R. In contrast, K7A showed low absorbance
intensity (λmax 396 nm) with a PLP/RNase molar ratio of
only 0.2, and K41A did not show any absorbance in the
wavelength range of the coenzyme. Only the Lys → Arg
mutants, which had retained the high affinity for PLP,
were screened for PLP-dependent catalytic activities
(Table 2).
Table 2: Catalytic activities of recombinant wild-type and mutant RNases.
kcat
a  kobs
b 
(s-1)( s -1)
RNase-PLP Ribonuclease activity (tRNA) Racemization (L-Alanine) Racemization (L-Aspartate) β-Decarboxylation (L-Aspartate)
Wild-typec 36 ± 1.0 (6 ± 1.0) × 10-7 (3 ± 0.5) × 10-7 (2 ± 0.2) × 10-7
K7R 35.6 ± 1.0 (6 ± 0.5) × 10-7 (7 ± 0.7) × 10-7 < 10-9d
K41Rc 0.036 ± 0.002 (2 ± 0.5) × 10-6 (3 ± 0.5) × 10-7 (4 ± 0.5) × 10-6
K7Ae 8 ± 0.5 - - -
K41Ae 0.0034 ± 0.0002 - - -
aRibonuclease activity was measured as described [41]; for details, see Methods. The ribonuclease activity of the recombinant wild-type and mutant 
RNases in the absence of PLP was comparable to that of the corresponding RNase-PLP complexes.
b The kobs value denotes the rate of the reaction (μmol·s-1) under the given conditions per μmol RNase-PLP adduct. PLP-dependent activities were 
measured at pH 7.5 and 25°C; the concentration of the RNase-PLP adduct was 11 mM; the substrate concentration was 20 mM (for details, see 
Methods). Results are the mean ± SE of three independent measurements. The rates of the PLP-dependent reactions in the absence of RNase were 
below the detection limit of 10-9 s-1.
c These enzymes catalyze the racemization of L-phenylalanine with a rate of (3 ± 0.4) × 10-7 s-1.
d Detection limit for a reaction with the Marfey assay is 10-9s-1.
e These RNase variants showed low affinity for PLP (see text), their PLP-dependent activities have not been measured.
Table 1: Rate constants of PLP-dependent reactions catalyzed by 
the wild-type RNase-PLP adducta
Substrateb Reactionc kobs × 107d 
(s-1)
RNase-PLP Free PLPe
L-Alanine Racemization 5.3 ± 2.0 < 0.01
D-Alanine Racemization 6.5 ± 1.0 < 0.01
L-Glutamate Racemization 1.2 ± 0.7 0.1 ± 0.05
D-Glutamate Racemization 3.1 ± 2.2 0.1 ± 0.05
L-Aspartate Racemization 3.3 ± 0.5 < 0.01
β-Decarboxylation 2.2 ± 0.5 < 0.01
D-Aspartate Racemization 2.2 ± 0.7 < 0.01
L-Phenylalanine Racemization 3.1 ± 1.2 < 0.01
D-Phenylalanine Racemization 2.2 ± 1.0 < 0.01
a The concentration of RNase-PLP and free PLP was 11 mM; the 
substrate concentration was 20 mM. The assays were run at pH 7.5 
and 25°C. For details of the analytical protocols, see Methods.
b Activities were tested and found below detection level (see 
Footnote e) with L-serine, D-serine, L-serine-O-sulfate, L-cysteine 
sulfinate, L-valine, L-norvaline, L-leucine, L-norleucine, L-isoleucine, L-
2-aminoadipate, 5-aminovalerate as substrates.
c No transamination reaction was detectable with any of the amino 
acids analyzed.
d The kobs value denotes the rate of the reaction (μmol·s-1) under the 
given conditions per μmol RNase-PLP adduct or PLP, respectively. 
The results are the mean ± SE of at least four independent 
measurements.
e Neither substrate consumption nor reaction products were 
detected with the Marfey assay after 336-h incubation of L- and D-
alanine and L- and D-phenylalanine or after 24-h incubation of L- and 
D-aspartate with the free cofactor (25 mM). Experiments with the L- 
or D-aspartate/oxalacetate pair could not be continued for more than 
24 h because of the inherent instability of oxalacetate [28]. In our 
experimental set-up, the detection limit for a reaction was of the 
order of 10-9 s-1 with the Marfey assay and 10-8 s-1 in the 
spectrophotometric assay for transamination (see Methods).BMC Biochemistry 2008, 9:17 http://www.biomedcentral.com/1471-2091/9/17
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The PLP-dependent catalytic properties of recombinant
wild-type RNase proved essentially the same as those of
the enzyme isolated from bovine pancreas. However, the
PLP-dependent catalytic activities of K41R were higher
than those of wild-type RNase. With K41R-PLP the β-
decarboxylation of L-aspartate to L-alanine (Fig. 4) and
the racemization of alanine were 20 and 3 times faster,
respectively, than with the wild-type enzyme; its ribonu-
clease activity, however, was three orders of magnitude
lower than that of wild-type RNase-PLP (Table 2). The
aspartate β-decarboxylase/ribonuclease activity ratio and
the alanine racemase/ribonuclease activity ratio of K41R-
PLP thus are 2 × 104 times and 3300 times, respectively,
higher than those of wild-type RNase-PLP. In this context,
it should be noted that the covalent binding of PLP to
RNase is reversible and does not impair its ribonuclease
activity (Footnote a in Table 2). In the case of RNaseK7R-
PLP, the ribonuclease and racemase activities are about
the same as those of the wild-type enzyme, whereas the β-
decarboxylase activity is more than two orders of magni-
tude lower.
The binding affinities of wild-type RNase and K41R for
PLP, PMP and both enantiomers of Nα-(5'-phosphopyri-
doxyl)-alanine (PPL)-alanine were determined by meas-
uring the quenching of the intrinsic fluorescence upon
addition of the ligand (Fig. 5 shows the fluorescence titra-
tion of RNaseK41R with PPL-L-alanine). The Kd values of
wild-type and mutant RNase proved to be similar and
showed a clearly higher affinity for both enantiomers of
PPL-alanine than for PLP and PMP (Table 3). Apparently,
both wild-type RNase and K41R interact not only with the
coenzyme but also with the substrate moiety of the coen-
zyme-substrate adduct.
Molecular modeling of RNase(K41R)-PLP
The simulation of the internal aldimine of RNase(K41R)
with PLP was based on a crystal structure of RNase con-
taining a phosphate ion bound in the active site (PDB
entry code 1SSC; [23]). The covalent aldimine bond
between PLP and Lys 7 of K41R together with the anchor-
ing of the phosphate group to specific amino acid residues
allowed to identify with good confidence the region
where the cofactor binds to RNase (Fig. 6). The position-
Fluorescence titration of RNase(K41R) with PPL-L-alanine Figure 5
Fluorescence titration of RNase(K41R) with PPL-L-
alanine. Fluorescence was measured with 5 μM 
RNase(K41R) in 50 mM 4-methylmorpholine pH 7.5 at 25°C. 
PPL-L-alanine concentrations were 10, 12, 15, 20, 25, 40 and 
50 μM. A, Fluorescence spectra; B, nonlinear regression 
analysis gives a K'd value of 23 μM. Bovine RNase A contains 
six tyrosine residues and no tryptophan residue [45].
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β-Decarboxylation and racemization of L-aspartate by  RNase(K41R)-PLP Figure 4
β-Decarboxylation and racemization of L-aspartate 
by RNase(K41R)-PLP. Recombinant RNase(K41R)-PLP ( , 
—) and wild-type RNase-PLP ( , --) were incubated with 20 
mM L-aspartate in 50 mM 4-methylmorpholine pH 7.5 at 
25°C. The concentration of RNase-PLP adduct was 11 mM in 
the case of the wild-type enzyme and 7 mM in the case of 
K41R. Samples of 20 μl were withdrawn at the indicated 
times and analyzed by derivatization with Marfey reagent and 
subsequent HPLC as described under Materials and Methods. 
The mean values ± SE of 5 different experiments with stand-
ard deviations are shown.
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ing of the cofactor was based on a crystallographic study
of three wild-type RNase derivatives with PLP [24]. Deriv-
ative B in that study contained PLP bound to Lys7 of wild-
type RNase. Due to unfortunate circumstances, the coor-
dinates of that structure are not available (Dr. M.
Vilanova, personal communication). Therefore, careful
visual inspection of Figure 2 (stereo) in [24] was
employed to place PLP in a corresponding position in our
RNase(K41R)-PLP model. Coordinate reconstruction
from the stereo figure was not attempted since Figure 2 in
[24] shows three superimposed structures. According to
our model, Arg41 contributes to the binding of the phos-
phate group of PLP. There appears to be no acidic residue
that could form a salt bridge with the pyridinium nitrogen
of the cofactor ring. Spectroscopic measurements suggest
that the cofactor in PLP-Lys7-RNase, in which PLP is
attached to the same lysine residue as in K41R-PLP, is
mainly solvent-exposed [25]. Our model is in accord with
this observation.
Discussion
In the emergence of a B6 protoenzyme, i. e. of a potential
progenitor of one of the four B6 enzyme families, the piv-
otal events conceivably were on the one hand the associa-
tion with PLP that endowed the prospective
protoapoenzyme with an entirely new catalytic potential
and on the other hand mutations that improved the PLP-
dependent catalytic activities as well as attenuated a possi-
bly preexisting catalytic activity. Attenuation and eventual
loss of a preexisting activity allows the evolutionary pres-
sure exerted upon the protein to shift to its newly acquired
catalytic function. If the original activity was essential for
the cell, preceding gene duplication had, of course, to pro-
cure two separate gene products, one maintaining the
original function, the other becoming a B6 protoenzyme.
RNase(K41R)-PLP corresponds to a plausible experimen-
tal reconstruction of a protein that has passed such a
crossroads of molecular evolution.
Criteria for a B6 protoenzyme
The mechanism of PLP-assisted transformation of amino
acids [1] and the course of the molecular evolution of B6
enzymes [4,5] suggest that a PLP-dependent protoenzyme
was equipped with the following features, all of which are
found in RNase(K41R)-PLP:
(i) The cofactor is covalently attached to the ε-amino
group of a lysine residue. The formation of the internal
aldimine 1 (Fig. 1) is found in all B6 enzymes catalyzing
reactions of amino acids. A number of observations argue
for the ubiquitous internal aldimine being an evolution-
Table 3: Dissociation equilibrium constant of wild-type RNase 
and K41R for PLP, PMP, PPL-L-alanine and PPL-D-alanine
K'
d
a
(μM)
Ligand Wild-type K41R
PLP 120 ± 5 140 ± 10
PMP 106 ± 5 107 ± 3
PPL-L-alanine 23 ± 1 23 ± 1
PPL-D-alanine 45 ± 1 40 ± 3
a The constants were determined by the quenching of the intrinsic 
fluorescence of RNase at pH 7.5 upon addition of the ligand (see 
Methods) as shown in Fig. 5 for RNase(K41R) and PPL-L-alanine. 
Results are the mean ± SE of three independent measurements.
Stereo cartoon representation of RNase(K41R)-PLP Figure 6
Stereo cartoon representation of RNase(K41R)-PLP. The cofactor and selected binding residues appear in stick mode, 
in green and atom colors. His119 is shown in two alternative conformations, which are also seen in the template structure 
[24].BMC Biochemistry 2008, 9:17 http://www.biomedcentral.com/1471-2091/9/17
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ary trait rather than a mechanistic necessity [4]. The most
weighty evidence for this notion is that the same PLP-
lysine linkage is also found in glucan phosphorylases, in
which the aldehyde group of PLP does not at all interact
with the substrate [26]. The encounter of PLP with a can-
didate protoapoenzyme must have been an infrequent
event given the likely very low concentration of either
reactant. Covalent binding of the cofactor prevented its
rapid loss, protected the reactive aldehyde group against
side reactions, and thus probably was of decisive selective
advantage in the emergence of B6 enzymes (for a more
detailed discussion, see [4]).
(ii) The formation of the internal aldimine 1 implicates
that the first covalent PLP-amino acid adduct, the external
aldimine  2, is formed through transimination (Fig. 1)
rather than de novo. In RNase(K41R), the affinity of which
for both enantiomers of PPL-alanine is higher than that
for PLP and PMP, a low-affinity binding site for the amino
acid substrate adjacent to the PLP-binding site apparently
facilitates the transimination step. The complete loss of
catalytic activity upon reduction of the internal imine
bond with borohydride documents that transimination is
as indispensable in RNase(K41R)-PLP as it is in B6
enzymes.
(iii) Transimination abolishes the covalent bond between
cofactor and proto-enzyme (Fig. 1), requiring noncova-
lent interactions to retain the coenzyme-substrate adduct
at the active site. RNase(K41R)-PLP also fulfills this pre-
condition.
(iv) The reaction specificity of RNase(K41R)-PLP is well
defined. The evolutionary pedigrees of the four known B6
enzyme families operating in the metabolism of amino
acids show that the protoenzymes first diverged into reac-
tion-specific catalysts, which then branched further and
acquired substrate specificity [4,5]. The only reactions cat-
alyzed by RNase(K41R)-PLP at measurable rate are the
racemization of amino acids and the β-decarboxylation of
L-aspartate. The assay with Marfey reagent [27,28] allows
to exclude any other potential reaction of the adduct of
PLP with the tested amino acids (Fig. 1). The joint occur-
rence of racemization and β-decarboxylation may be
explained by the similarity of the two reaction pathways,
which have in common the deprotonation at Cα of the
external aldimine 2 producing the quinonoid intermedi-
ate 3. In the case of L-amino acid substrates, the deproto-
nation of the aldimine occurs from its re  side. The
racemization of L-aspartate as catalyzed by K41R-PLP is by
one order of magnitude slower than the β-decarboxyla-
tion of the same substrate. The rate-limiting step in the
racemization of L-aspartate thus seems to be the reproto-
nation of the quinonoid intermediate 4 from the si side to
give D-aspartate. The substrate specificity of K41R-PLP, as
expected from a B6 protoenzyme, is less strictly defined
than its reaction specificity; in addition to alanine, which
is the best substrate, acidic and aromatic amino acids are
accepted as substrates. The substrate and reaction specifi-
city of B6 enzymes may be changed by substitution of crit-
ical active-site residues [29-33].
(v) The acceleration factors that are due to the protein
moiety of RNase(K41R)-PLP, i.e. the factors, by which the
rates of the RNase(K41R)-PLP-catalyzed reactions exceed
the rates of the PLP-catalyzed reactions in the absence of
RNase(K41R), are >103  for both the racemization of
alanine and the β-decarboxylation of L-aspartate (Table
2). Only minimum values of the acceleration factors can
be given, because in the presence of PLP alone the rates of
both reactions are unmeasurably slow (for the detection
limits of the assays, see Table 1, Footnote e). The catalytic
contribution of the cofactor can only be approximately
assessed; previous experiments have given an estimate of
the acceleration factor due to PLP in the absence of a pro-
tein catalyst of about 104 for the β-elimination reaction of
β-chloroalanine and the transamination reaction [6]. The
conjoint acceleration factor of RNase(K41R)-PLP may
thus be assumed to be >107.
Mechanistic aspects
The B6 enzymes that act on amino acid substrates invaria-
bly utilize the active-site lysine residue that covalently
binds PLP as the general base group abstracting the proton
from Cα(3). Molecular modeling shows that such a role
for Lys7 is highly improbable in RNase(K41R)-PLP, in
which one face of PLP is fully and the other partly accessi-
ble to the solvent. Most likely, bulk water molecules
deprotonate the coenzyme-substrate adduct at Cα and, in
the racemization reaction, reprotonate it from the oppo-
site side.
The previously generated PLP-dependent catalytic anti-
body 15A9 [6,7], the high-resolution crystal structure of
which has recently been determined [8], does not possess
a PLP-binding active-site lysine residue. Nevertheless,
antibody 15A9 catalyzes the transamination reaction of
D-alanine and other hydrophobic amino acids with PLP
and is by 3 orders of magnitude catalytically more active
than RNase(K41R). The handicap of RNase(K41R)-PLP vs
the catalytic antibody might be a less favorable position-
ing of PLP and the amino acid substrate for forming a pla-
nar coenzyme-substrate adduct. Another reason for the
relatively slow reactions might be an orientation of the
Cα-H bond that is unfavorable for deprotonation. In B6
enzymes, the bond to be broken invariably lies, together
with the Cα-N bond, in a plane orthogonal to the plane of
the coenzyme-imine π system [3,34]. This conformation
corresponds to minimum free energy of the transition
state for bond cleavage, as it allows maximum σ-π overlapBMC Biochemistry 2008, 9:17 http://www.biomedcentral.com/1471-2091/9/17
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between the bond to be broken and the pyridine-imine
system.
For improving the efficacy of RNase(K41R) as a PLP-
dependent protein catalyst directed molecular evolution
would seem to be the method of choice. Previous studies
using forced evolution have succeeded to change the sub-
strate specificity of B6 enzymes. Repeated rounds of meta-
bolic panning of randomly mutagenized bacterial
aspartate aminotransferase increased its activity toward
branched-chain amino acids by a factor of 106, with,
remarkably, only a single residue out of a total of 17 muta-
genized residues interacting directly with the substrate
[35]. Similarly, forced evolution replacing 13 amino acid
residues endowed aspartate aminotransferase with tyro-
sine aminotransferase activity that was two orders of mag-
nitude higher than that of the parent wild-type enzyme
[36].
Conclusion
RNase(K41R)-PLP fully complies with all reasonable cri-
teria for a model B6 protoenzyme. Conceivably, the ances-
tor proteins of each of the four B6 enzyme families were
selected from proteins with properties similar to those of
RNase(K41R). The selection criteria very likely included
the same constraints that guided the choice of
RNase(K41R) as model B6 protoenzyme and were consid-
ered in the selection of antibody 15A9 [6,7]. The existence
of four B6 enzyme families of entirely different fold [2-5]
indicates that the structural requirements for efficient pro-
tein-assisted pyridoxal catalysis can be met with quite dif-
ferent protein scaffolds. Conversely, comparison of
enzyme structures shows that in numerous instances one
and the same protein fold renders entirely different cata-
lytic functions, e. g. the enzymes of the alanine racemase
family of B6 enzymes are (βα)8 proteins and remotely but
definitely related to other enzymes with quite diverse
non-PLP-dependent catalytic activities [4,37].
The present study propounds RNase(K41R) as a plausible
model B6 protoenzyme; its evolutionary potential was,
however, not tested. Future attempts to improve the cata-
lytic performance of RNase(K41R)-PLP may be expected
to contribute to a deepened appreciation of the interplay
of chance and chemical-mechanistic necessity during the
molecular evolution of PLP-dependent enzymes.
Methods
Site-directed mutagenesis of RNase, expression and 
purification of recombinant wild-type and mutant RNase
The cDNA sequence [38] encoding bovine pancreatic
RNase A (E.C. 3.1.27.5) was inserted into the NdeI/Hin-
dIII sites of the expression vector pET22b(+) (Novagen,
Darmstadt, Germany). The recombinant plasmid
pET22b/RNase A was used for oligonucleotide-directed
mutagenesis according to Kunkel [39]. The synthetic oli-
gonucleotides CGT CGT CGG GCT AAA CTC GCC, CGT
CGT CGG CGT AAA CTC GCC, CTA GCT ACG GCT GGT
CAC TTG and CTA GCT ACG CGT GGT CAC TTG were
used for the K7R, K7A, K41R and K41A amino acid substi-
tutions, respectively. The mutations were confirmed by
determination of the nucleotide sequences on both
strands. Wild-type and mutant enzymes were expressed in
the E. coli strain BL21 (Novagen, Darmstadt, Germany)
and purified essentially as described [40]. The maximum
yield was 60 mg pure recombinant enzyme per liter of cul-
ture medium. The purified enzymes were stored at -20°C
in 50 mM 4-methylmorpholine pH 7.5 at a concentration
of 100–200 mg/ml. Ribonuclease activity was determined
by following the changes in A300 with yeast RNA (Sigma,
Milan, Italy) as substrate (0.5 mg/ml) in 0.1 M sodium
acetate pH 5.0 [41].
Preparation of RNase-PLP adduct
A solution of bovine pancreatic RNase A (type II from
Sigma, Milan, Italy) or recombinant wild-type and mutant
RNase at a concentration of 10–50 mg/ml in 50 mM 4-
methylmorpholine pH 7.5 was incubated at 25°C in the
dark for 15 min with a 5-fold molar excess of PLP. Excess
PLP was removed through Sephadex G-25 chromatogra-
phy. The protein-containing fractions were pooled, con-
centrated and stored frozen at -20°C in the dark at a
protein concentration of about 20 mM. The RNase-PLP
adduct was stable under these conditions for at least one
month; in solution at 25°C it proved stable for at least 48
h. RNase concentration was calculated from the absorb-
ance at 278 nm with a molar absorption coefficient of
9800 M-1 cm-1 [42]. PLP concentration was calculated
from the absorbance at 388 nm using a molar absorption
coefficient of 4900 M-1 cm-1 at neutral pH [20]. The extent
of modification of RNase with PLP was determined from
the absorbance at 388 nm of free PLP after dissociation of
the RNase-PLP adduct in 0.1 N NaOH using a molar coef-
ficient of 6600 M-1 cm-1 [20]. The PLP-lysine aldimine
double bond in the RNase-PLP adduct was reduced by
adding a freshly prepared solution of NaBH4 (final con-
centration 2 mM) at room temperature [17]. Immediately
after bleaching of the solution, excess NaBH4 was sepa-
rated from the reduced enzyme by Sephadex G-25 chro-
matography.
Assay for detection of PLP-dependent transformations of 
amino acids
RNase-PLP adduct (11 mM) was incubated in 50 mM 4-
methylmorpholine pH 7.5 at 25°C in the dark with the
amino acid substrate (20 mM). The respective assays with
free PLP (11 or 25 mM) instead of the RNase-PLP adduct
were performed in the presence of the cognate oxo acids
(10 mM or 25 mM, respectively) to reverse the potential
transamination of PLP to catalytically inert PMP [6]. TheBMC Biochemistry 2008, 9:17 http://www.biomedcentral.com/1471-2091/9/17
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solutions were 0.2-μm filtrated. Samples of 20 μl were
withdrawn at different times during a period of 48 h. For
determination of L-and D-amino acids and of amines as
decarboxylation products, samples of the reaction mixture
were deproteinized by centrifugation at 12,000 g for 30
min with Microcon 3 ultrafiltration devices (Millipore),
derivatized with Marfey reagent [27] and analyzed by
reverse-phase HPLC [29]. Newly generated peaks were
identified and quantified by comparison with reference
substances. The assay thus detects both the consumption
of amino acid substrate and the formation of any product,
including the enantiomer of the substrate, as long as the
product carries a primary amino group [27,28].
For measuring transaminase activity, samples were with-
drawn at intervals during a period of 48 h and analyzed
for a decrease in A408 (wild-type enzyme), A400 (K41R) or
A396 (K7R), reflecting a decrease in protein-bound PLP, as
well as for an increase in A325 to detect PMP as transami-
nation product. In the assay for serine dehydratase activ-
ity, samples of the reaction mixture were deproteinized as
above and directly analyzed for pyruvate with lactate
dehydrogenase and NADH [30].
Determination of dissociation equilibrium constants
The K'd values of RNase for PLP, PMP and PPL-L-alanine
and PPL-D-alanine, prepared by reduction of the PLP-
amino acid adducts with sodium borohydride [6], were
determined in 50 mM 4-methylmorpholine pH 7.5 at
25°C by measuring the quenching of the intrinsic fluores-
cence of the protein (excitation wavelength 279 nm;
wavelength of maximum emission 306 nm). The concen-
tration of the enzyme was 5 μM; the concentrations of the
PLP, PMP and PPL-amino acids were in the range of
10–200  μM.  K'd  values were calculated by nonlinear
regression analysis.
Molecular modeling
A molecular model of the internal aldimine of
RNase(K41R) with PLP was built based on a crystal struc-
ture of wild-type RNase containing a phosphate ion (PDB
code 1SSC, Ref. [23]) and on a study of three wild-type
RNase-PLP adducts, among which one contained PLP cov-
alently attached to Lys7 of wild-type RNase [24]. Lys41
was mutated to arginine with the program Coot [43], and
the position of its side chain manually optimized for
binding the phosphate group of PLP. The cofactor (posi-
tioned as in Ref. [24]) was mainly solvent-exposed, with
one face fully exposed and the other partly accessible, in
agreement with previous spectroscopic measurements
[25]. In a final step, the model was energy-minimized
with Phenix [44]. In this phase, the geometry and stereo-
chemistry of the imine bond between the cofactor and
Lys7 were optimized.
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